Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Buprenorphine exposure levels to optimize treatment outcomes in opioid use disorder
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 13, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-11-18
DOI
10.3389/fphar.2022.1052113
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Effect of sustained high buprenorphine plasma concentrations on fentanyl-induced respiratory depression: A placebo-controlled crossover study in healthy volunteers and opioid-tolerant patients
- (2022) Laurence M. Moss et al. PLoS One
- Modeling buprenorphine reduction of fentanyl-induced respiratory depression
- (2022) Erik Olofsen et al. JCI Insight
- Has the treatment gap for opioid use disorder narrowed in the U.S.?: A yearly assessment from 2010 to 2019"
- (2022) Noa Krawczyk et al. INTERNATIONAL JOURNAL OF DRUG POLICY
- Trends in US Emergency Department Visits for Mental Health, Overdose, and Violence Outcomes Before and During the COVID-19 Pandemic
- (2021) Kristin M. Holland et al. JAMA Psychiatry
- ASSESSMENT OF CRAVING IN OPIOID USE DISORDER: PSYCHOMETRIC EVALUATION AND PREDICTIVE VALIDITY OF THE OPIOID CRAVING VAS
- (2021) Brent Boyett et al. DRUG AND ALCOHOL DEPENDENCE
- Outcomes of a single-arm implementation trial of extended-release subcutaneous buprenorphine depot injections in people with opioid dependence
- (2021) Michael Farrell et al. INTERNATIONAL JOURNAL OF DRUG POLICY
- Recovery From Opioid Use Disorder (OUD) After Monthly Long-acting Buprenorphine Treatment
- (2020) Walter Ling et al. Journal of Addiction Medicine
- Association of OPRM1 Functional Coding Variant With Opioid Use Disorder
- (2020) Hang Zhou et al. JAMA Psychiatry
- Signal of increased opioid overdose during COVID-19 from emergency medical services data
- (2020) Svetla Slavova et al. DRUG AND ALCOHOL DEPENDENCE
- A Delta-Opioid Receptor Gene Polymorphism Moderates the Therapeutic Response to Extended-Release Buprenorphine in Opioid Use Disorder
- (2020) Henry R Kranzler et al. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
- Opioid Overdose–Related Emergency Department Visits and Accidental Deaths during the COVID-19 Pandemic
- (2020) Luke N. Rodda et al. JOURNAL OF URBAN HEALTH-BULLETIN OF THE NEW YORK ACADEMY OF MEDICINE
- COVID-19 risk and outcomes in patients with substance use disorders: analyses from electronic health records in the United States
- (2020) Quan Qiu Wang et al. MOLECULAR PSYCHIATRY
- The Opioid Epidemic Within the COVID-19 Pandemic: Drug Testing in 2020
- (2020) Justin K. Niles et al. Population Health Management
- Efficacy and safety of a monthly buprenorphine depot injection for opioid use disorder: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
- (2019) Barbara R Haight et al. LANCET
- Patient-centered Outcomes in Participants of a Buprenorphine Monthly Depot (BUP-XR) Double-blind, Placebo-controlled, Multicenter, Phase 3 Study
- (2019) Walter Ling et al. Journal of Addiction Medicine
- Replication of the pharmacogenetic effect of rs678849 on buprenorphine efficacy in African–Americans with opioid use disorder
- (2018) Richard C. Crist et al. PHARMACOGENOMICS JOURNAL
- Effect of Buprenorphine Weekly Depot (CAM2038) and Hydromorphone Blockade in Individuals With Opioid Use Disorder
- (2017) Sharon L. Walsh et al. JAMA Psychiatry
- Population Pharmacokinetic Modeling After Repeated Administrations of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Use Disorder
- (2016) Celine M. Laffont et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Sustained-Release Buprenorphine (RBP-6000) Blocks the Effects of Opioid Challenge With Hydromorphone in Subjects With Opioid Use Disorder
- (2016) Azmi F. Nasser et al. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY
- Neurobiologic Advances from the Brain Disease Model of Addiction
- (2016) Nora D. Volkow et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Population Pharmacokinetic and Pharmacodynamic Modelling Approach to Support the Clinical Development of RBP-6000, a New, Subcutaneously Injectable, Long-Acting, Sustained-Release Formulation of Buprenorphine, for the Treatment of Opioid Dependence
- (2014) Azmi F. Nasser et al. CLINICAL PHARMACOKINETICS
- Buprenorphine maintenance and mu-opioid receptor availability in the treatment of opioid use disorder: Implications for clinical use and policy
- (2014) Mark K. Greenwald et al. DRUG AND ALCOHOL DEPENDENCE
- A Review of Buprenorphine Diversion and Misuse
- (2014) Michelle R. Lofwall et al. Journal of Addiction Medicine
- Use of a linearization approximation facilitating stochastic model building
- (2014) Elin M. Svensson et al. JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS
- Treatment retention among patients randomized to buprenorphine/naloxone compared to methadone in a multi-site trial
- (2013) Yih-Ing Hser et al. ADDICTION
- Patient characteristics associated with buprenorphine/naloxone treatment outcome for prescription opioid dependence: Results from a multisite study
- (2013) Jessica A. Dreifuss et al. DRUG AND ALCOHOL DEPENDENCE
- An Intronic Variant in OPRD1 Predicts Treatment Outcome for Opioid Dependence in African-Americans
- (2013) Richard C Crist et al. NEUROPSYCHOPHARMACOLOGY
- Yohimbine increases opioid-seeking behavior in heroin-dependent, buprenorphine-maintained individuals
- (2012) Mark K. Greenwald et al. PSYCHOPHARMACOLOGY
- The genetics of addiction—a translational perspective
- (2012) A Agrawal et al. Translational Psychiatry
- A Fast Method for Testing Covariates in Population PK/PD Models
- (2011) Akash Khandelwal et al. AAPS Journal
- Prediction-Corrected Visual Predictive Checks for Diagnosing Nonlinear Mixed-Effects Models
- (2011) Martin Bergstrand et al. AAPS Journal
- Uniform assessment and ranking of opioid Mu receptor binding constants for selected opioid drugs
- (2011) Donna A. Volpe et al. REGULATORY TOXICOLOGY AND PHARMACOLOGY
- Behavioral economic analysis of opioid consumption in heroin-dependent individuals: Effects of alternative reinforcer magnitude and post-session drug supply
- (2009) Mark K. Greenwald et al. DRUG AND ALCOHOL DEPENDENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationPublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More